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Abstract 
Chronic myeloproliferative neoplasms (CMPNs) are clonal disorders of the 
hematopoietic stem cells, characterized by abnormal proliferation and survival of one 
or more cells of the myeloid lineage. BCR-ABL1 negative CMPNs are a heterogeneous 
group of diseases for which the molecular pathogenesis is not well understood. Over 
the last years some genetic alterations have been described, most of them activating 
some tyrosine kinase genes playing a role similar to ABL1 in CML. Tyrosine kinases 
(TK) have an important role in cell growth and oncogenesis. Deregulation of TK genes 
(mainly due to translocations, amplifications or point mutations) can result in 
constitutive activation of the signalling pathways in which they are involved, causing 
the abnormal proliferation and survival that characterize these pathologies. In this 
study, we have analysed all genes from the families Jak (JAK1, JAK2, JAK3 and 
TYK2), Abl (ABL1 and ABL2) and Syk (SYK and ZAP70) of TKs. All of them code for 
cytoplasmic tyrosine kinase proteins and some of them have been found mutated in 
CMPNs and in other tumor types. We have used FISH to detect cryptic rearrangements 
and dHPLC to detect sequence mutations on samples from 44 BCR-ABL1 negative and 
V617FJAK2 negative CMPN patients. Both analyses have shown that these genes are 
no frequently mutated in these diseases, implying that lesions in other genes must be 
involved in the pathogenesis of these diseases.  
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